Novartis India Ltd Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Cr

Standalone Quarterly Results

Mar'26

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Quarterly Analysis Highlights - YoY

Net Sales

YoY Growth in quarter ended Mar 2026 is 7.95% vs 3.34% in Mar 2025

Standalone Net Profit

YoY Growth in quarter ended Mar 2026 is -13.82% vs 99.59% in Mar 2025

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Mar 2026 is -13.76% vs 113.29% in Mar 2025

Interest

YoY Growth in quarter ended Mar 2026 is -41.67% vs -25.00% in Mar 2025

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025

Compare Quarterly Results Of Novartis India With

Select Peers

Figures in Cr

Standalone Quarterly Results

Change(INR)

Change(%)

Net Sales

90.55

631.68

-541.13

-85.67%

Other Operating Income

0.00

Total Operating income

90.55

631.68

-541.13

-85.67%

Raw Material Cost

0.00

399.29

-399.29

-100.00%

Purchase of Finished goods

68.34

12.12

56.22

463.86%

(Increase) / Decrease In Stocks

-16.16

-5.93

-10.23

-172.51%

Employee Cost

4.35

23.21

-18.86

-81.26%

Power Cost

0.00

Manufacturing Expenses

0.00

Selling and Distribution Expenses

0.00

Other Expenses

13.40

123.71

-110.31

-89.17%

Total Expenditure (Excl Depreciation)

69.93

552.40

-482.47

-87.34%

Operating Profit (PBDIT) excl Other Income

20.62

79.28

-58.66

-73.99%

Other Income

10.01

0.83

9.18

1,106.02%

Operating Profit (PBDIT)

30.63

80.11

-49.48

-61.77%

Interest

0.07

6.59

-6.52

-98.94%

Exceptional Items

0.00

Gross Profit (PBDT)

30.56

73.52

-42.96

-58.43%

Depreciation

0.42

14.95

-14.53

-97.19%

Profit Before Tax

30.14

58.57

-28.43

-48.54%

Tax

4.89

13.61

-8.72

-64.07%

Provisions and contingencies

0.00

Profit After Tax

25.25

44.96

-19.71

-43.84%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

25.25

44.96

-19.71

-43.84%

Equity Capital

12.34

91.27

-78.93

-86.48%

Face Value

5.00

10.00

0.00

Reserves

0.00

Earnings per share (EPS)

10.23

4.93

5.30

107.51%

Diluted Earnings per share

10.23

4.93

5.30

107.51%

Operating Profit Margin (Excl OI)

22.77%

12.55%

0.00

10.22%

Gross Profit Margin

33.75%

11.64%

0.00

22.11%

PAT Margin

27.89%

7.12%

0.00

20.77%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 90.55 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is 5.41% vs -4.90% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 7.95% vs 3.34% in Mar 2025

Quarterly - Standalone Net Profit

Standalone Net Profit 25.25 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is 56.93% vs -33.57% in Dec 2025

YoY Growth in quarter ended Mar 2026 is -13.82% vs 99.59% in Mar 2025

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 20.62 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is -7.78% vs -6.37% in Dec 2025

YoY Growth in quarter ended Mar 2026 is -13.76% vs 113.29% in Mar 2025

Quarterly - Interest

Interest 0.07 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is -92.86% vs 790.91% in Dec 2025

YoY Growth in quarter ended Mar 2026 is -41.67% vs -25.00% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 22.77%

in Mar 2026

Figures in %

QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025

YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025